Cancer Treatment Centers of America: Clinical Trials
Learn More About This Topic: Chat with Us | Email Us
Phase I/II, Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumor
Summary
This study is being conducted to provide supervised access to treatment with TheraSphere to eligible patients with primary and metastatic cancer to the liver. It is also being offered to evaluate patient experience and toxicities associated with TheraSphere treatment. In addition, the study will evaluate predisposing factors that may influence results and toxicity.
For More Information:
Please contact one of our Oncology Information Specialists at 1-800-615-3055 to learn more about this clinical trial. Oncology Information Specialists are available 24 hours a day, 7 days a week, 365 days a year.
